FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s ...
Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma ...
Three-phase four-switch inverters represent a cost‐effective and efficient alternative to conventional inverter topologies, offering reduced component counts while maintaining robust performance.
Exelixis, Inc. (Nasdaq: EXEL) today announced detailed results from STELLAR-303, a global phase 3 pivotal trial evaluating zanzalintinib in combination with atezolizumab (Tecentriq®) versus ...
KAWASAKI, Japan--(BUSINESS WIRE)--Toshiba Electronic Devices & Storage Corporation ("Toshiba") has today started to provide engineering samples of a gate driver [1] IC, "TB9084FTG,” for three-phase ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback